Monroe Capital acted as sole lead arranger and administrative agent on the funding of a $120 million senior credit facility to support the recapitalization of an infusion therapy business by a private equity sponsor.
The company is a provider of home and alternate-site infusion therapy and complex specialty pharmacy solutions to patients. The company’s therapy management programs span across complex disease states, including hemophilia, immune deficiency, autoimmune disorders, infectious disease, heart failure and rare diseases.
